Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm

Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm

Item

http://www.wikidata.org/entity/Q58766500

Q58766500

about

Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm

Item

http://www.wikidata.org/entity/Q58766500

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Up-Titration Strategy After DP ...... riable Basal Insulin Algorithm

@en

Up-Titration Strategy After DP ...... riable Basal Insulin Algorithm

@nl

type

Item

label

Up-Titration Strategy After DP ...... riable Basal Insulin Algorithm

@en

Up-Titration Strategy After DP ...... riable Basal Insulin Algorithm

@nl

prefLabel

Up-Titration Strategy After DP ...... riable Basal Insulin Algorithm

@en

Up-Titration Strategy After DP ...... riable Basal Insulin Algorithm

@nl

P1476

Up-Titration Strategy After DP ...... riable Basal Insulin Algorithm

@en

P2093

Hiroji Kitazato

http://www.w3.org/2001/XMLSchema#string

Koki Shin

http://www.w3.org/2001/XMLSchema#string

Makiko Sasamoto

http://www.w3.org/2001/XMLSchema#string

Mariko Higa

http://www.w3.org/2001/XMLSchema#string

Masahiko Miyagi

http://www.w3.org/2001/XMLSchema#string

Motoyuki Tamaki

http://www.w3.org/2001/XMLSchema#string

Munehide Matsuhisa

http://www.w3.org/2001/XMLSchema#string

Naoki Kumashiro

http://www.w3.org/2001/XMLSchema#string

Takahisa Hirose

http://www.w3.org/2001/XMLSchema#string

P2860

One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial

Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Incretin physiology and pathophysiology from an Asian perspective

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

A retrospective, case-note survey of type 2 diabetes patients prescribed incretin-based therapies in clinical practice.

Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trial.

P2888

s13300-018-0486-1

P304

1959-1968

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-018-0486-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroshi Uchino

P577

2018-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30121725

http://www.w3.org/2001/XMLSchema#string

P932

6167274

http://www.w3.org/2001/XMLSchema#string

Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm

about

Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932